
Preliminary report May 1, 1998 – April 30, 1999
• The pretax loss was SEK 140 M (252).
• Net sales for comparable units were SEK 1,884 M (1,555), an increase of 21%
• A new product program for radiation oncology, Elekta Precise Treatment System, was introduced.
• A new generation of the Leksell Gamma Knife, Model C, was launched.
For further information, please contact:
Lars Jonsteg, Vice President, Corporate Relations, Elekta AB (publ),
Tel: +46 8-587 254 82.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
![]() The full report |
